Mike Hennessy

Articles

Innovation Brings New Challenges

August 13th 2016

The right technology can make a wonderful difference, but what if everybody has it? Such is the case with patient assistance-funding software, the use of which is now becoming widespread.

Inspiring Stories Emerge From the Giants of Cancer Care Initiative

August 11th 2016

As summer comes to a close, I want to turn your attention to the upcoming 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®, which takes place in New York City, November 9-11, 2016.

The Art of Immunotherapy

August 3rd 2016

There’s no question that checkpoint blockade immunotherapy agents, most notably those directed at the PD-1/PD-L1 pathway, will continue to grow in importance as an anticancer modality in a rising number of tumor types.

No Time to Rest

July 24th 2016

Although it is gratifying to take stock of the many advances that have been made in the oncology field in recent years, it remains vitally important that we keep in mind just how much work there remains to be done.

The OCM Involves A Lot of Guesswork

July 5th 2016

The Oncology Care Model blew into town this month, rattling the shutters and bringing with it a lot of dust.

PSA Recommendations Challenged After Analysis of PLCO Trial Data

June 25th 2016

During the annual American Urological Association meeting leaders in urology presented groundbreaking research, new clinical guidelines, and the latest advances in urologic medicine.

The Next Big Thing

June 10th 2016

Sometimes it seems as though we’ve become addicted to a big story mentality when it comes to the American Society of Clinical Oncology Annual Meeting.

Driving Change for the Future of Radiation Oncology

June 5th 2016

As we approach the 1-year anniversary of Contemporary Radiation Oncology (CRO) publication, it occurs to me, upon reflection, how much change has occurred in the utilization of radiation oncology for cancer treatment in recent months.

A Model for the Moonshot?

June 4th 2016

Turning around any ship of state, particularly one as large and unwieldy as the oncology research establishment, is always going to be a slow-moving and laborious undertaking.

CMS Puts On Its Poker Face

June 1st 2016

The saying on Wall Street is "sell in May and go away," but there's no detaching from the cliffhanger that CMS has left in the air.

Something’s Gotta Give

May 16th 2016

Value-based care is becoming a new catch phrase in American medicine, especially in the oncology arena.

Reform-Minded CMS Doesn’t Let Up on Value Demands

May 1st 2016

A not-so-subtle change in the physician drug payment scheme from The Centers for Medicare & Medicaid Services could be the proverbial straw that broke the camel’s back.

Trouble Behind the Scenes

April 21st 2016

The cascade of news about cancer research—whether it’s about a new drug, biomarker, or treatment approach—has become an ever-present feature of the oncology landscape

Pushing the Envelope

April 12th 2016

We’re talking about a certain type of “more”— more intervention earlier and more effectively in the natural history of a malignancy in order to prevent a recurring or metastatic manifestation of a cancer.

Medicare's Rx for Change: No Spoonful of Sugar

April 12th 2016

The ongoing value transition got a bit more real in March when The Centers for Medicare & Medicaid Services introduced a proposal for Medicare Part B drug payment changes that would even out the margins that physicians make on drug sales.

Urology Practices Thrive When Administrative and Clinical Champions Emerge

April 2nd 2016

With new therapies in prostate, kidney, and bladder cancer on the horizon and tightening regulatory and reimbursement restrictions in place, urologists need to adapt to a quickly changing landscape.

Demanding Change

March 23rd 2016

There are many reasons why we should change the way we approach cancer research and evaluate potential new drugs.

A Good Problem to Have

March 15th 2016

Today, there are multiple choices of regimens in two different modalities that can either prolong survival or allow patients to live without disease progression or recurrence for several years.

"Press '1' to Speak to Your Next Patient"

March 12th 2016

In this month’s issue of Oncology Business Management, we take you to Hawaii and Alaska to peel back the curtains on how oncologists in remote corners of the United States have innovated to keep their businesses vibrant and effective.

The March of Technology

February 22nd 2016

The creation of new technology is a complicated, risky business regardless of the area of healthcare or industry. The cover story in this issue, “Proton Beam Centers Multiply Despite Economic Risks,” illustrates that the oncology field is no exception to those rules of the marketplace.

NEXT PAGE
PREVIOUS PAGE